Mice Model Market is estimated to be US$ 2.77 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
May 02, 2022 09:52 ET
|
PMI
Covina, May 02, 2022 (GLOBE NEWSWIRE) -- Chronic diseases are becoming more common, and there is a growing demand for mice models in cancer research to better understand genetics. In addition,...
Taconic Biosciences Adds New Humanized Immune System (HIS) Model to Its Portfolio For Immuno-Oncology Research
January 18, 2022 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the huNOG-EXL EA (Early Access)...
Taconic Biosciences Launches TruIMPORT™ Importation Solution
May 27, 2021 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., May 27, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces a significant enhancement to the Taconic-Cyagen...
Taconic Biosciences Launches New COVID-19 Mouse Model
April 29, 2021 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., April 29, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This...
Taconic Biosciences Expands Scientific Advisory Board
March 15, 2021 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces Monica Gostissa, PhD, has joined its...
Taconic Biosciences Expands Immuno-oncology Animal Model Portfolio
January 18, 2021 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Jan. 18, 2021 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an expansion of its immuno-oncology...
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
December 03, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, New York, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the new ExpressMODEL®: Random...
Taconic Biosciences launches critical model for COVID-19 research
October 26, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces immediate humanized ACE2 mouse model...
Taconic Biosciences Launches Rapid Restart™ Program
May 18, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., May 18, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid...
Taconic Biosciences Supports Coronavirus Research
March 20, 2020 09:00 ET
|
Taconic Biosciences
RENSSELAER, N.Y., March 20, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts...